Top Stories FDA Approves Wegovy for Liver Disease; Novo Nordisk Shares Surge BREAKING: The FDA has just approved Wegovy for the treatment of a specific form of liver disease, sending shares of Novo Nordisk surging on... Editorial3 hours ago